首页> 外文期刊>European Journal of Medicinal Chemistry: Chimie Therapeutique >Subtle modifications to a thieno[2,3-d]pyrimidine scaffold yield negative allosteric modulators and agonists of the dopamine D-2 receptor
【24h】

Subtle modifications to a thieno[2,3-d]pyrimidine scaffold yield negative allosteric modulators and agonists of the dopamine D-2 receptor

机译:对噻吩的微妙修饰[2,3-D]嘧啶支架产生负变性调节剂和多巴胺D-2受体的激动剂

获取原文
获取原文并翻译 | 示例
           

摘要

We recently described a structurally novel series of negative allosteric modulators (NAMs) of the dopamine D-2 receptor (D2R) based on thieno[2,3-d]pyrimidine 1, showing it can be structurally simplified to reveal low molecular weight, fragment-like NAMs that retain robust negative cooperativity, such as 3. Herein, we report the synthesis and functional profiling of analogues of 3, placing specific emphasis on examining secondary and tertiary amino substituents at the 4-position, combined with a range of substituents at the 5/6-positions (e.g. aromatic/aliphatic carbocycles). We identify analogues with diverse pharmacology at the D2R including NAMs with sub-mu M affinity (9h) and, surprisingly, low efficacy partial agonists (9d and 9i). (C) 2019 Published by Elsevier Masson SAS. All rights reserved.
机译:我们最近描述了基于Thieno [2,3-D]嘧啶1的多巴胺D-2受体(D2R)的结构新颖的阴性变构调节剂(NAMS),显示它可以在结构上简化以显示低分子量,片段 保持稳健的负合作症,例如3.在此,我们报告了3的类似物的合成和功能性分析,在4-位在4立方中施加特异性强调检查仲和叔氨基取代基,与一系列取代基合并 5/6位(例如芳族/脂肪族碳缩乳)。 我们在D2R中识别具有不同药理的类似物,包括NAMS与亚μm亲和力(9h),并且令人惊讶地,低疗效部分激动剂(9d和9i)。 (c)2019年由Elsevier Masson SA发布。 版权所有。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号